A detailed history of Synovus Financial Corp transactions in Illumina, Inc. stock. As of the latest transaction made, Synovus Financial Corp holds 4,058 shares of ILMN stock, worth $527,783. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,058
Previous 4,110 1.27%
Holding current value
$527,783
Previous $564,000 25.0%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$101.05 - $133.57 $5,254 - $6,945
-52 Reduced 1.27%
4,058 $423,000
Q1 2024

May 14, 2024

SELL
$127.73 - $147.2 $24,779 - $28,556
-194 Reduced 4.51%
4,110 $564,000
Q3 2023

Nov 13, 2023

BUY
$128.91 - $192.44 $554,828 - $828,261
4,304 New
4,304 $590,000
Q4 2022

Feb 06, 2023

BUY
$187.24 - $242.74 $215,326 - $279,151
1,150 New
1,150 $232,000
Q2 2022

Aug 10, 2022

SELL
$181.58 - $368.0 $1.17 Million - $2.38 Million
-6,462 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$303.87 - $423.8 $113,039 - $157,653
372 Added 6.11%
6,462 $2.25 Million
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $216,008 - $262,378
622 Added 11.38%
6,090 $2.32 Million
Q3 2021

Nov 08, 2021

BUY
$405.61 - $524.84 $2.22 Million - $2.87 Million
5,468 New
5,468 $2.22 Million
Q3 2020

Nov 09, 2020

SELL
$268.51 - $400.74 $85,386 - $127,435
-318 Closed
0 $0
Q2 2020

Aug 10, 2020

SELL
$256.46 - $373.01 $28,210 - $41,031
-110 Reduced 25.7%
318 $116,000
Q1 2020

Apr 24, 2020

BUY
$209.2 - $335.53 $46,860 - $75,158
224 Added 109.8%
428 $116,000
Q4 2019

Feb 06, 2020

BUY
$288.29 - $335.49 $1,441 - $1,677
5 Added 2.51%
204 $68,000
Q1 2018

May 07, 2018

BUY
$209.54 - $253.91 $41,698 - $50,528
199 New
199 $47,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $20.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.